YAP1 and infection: In contrast with PP2 and A-419259 treatment, serovar L2-infected cells treated with dasatinib exhibited significant attenuation of YAP nuclear incidence relative to DMSO-treated cells, suggesting that infection-enhanced YAP nuclear incidence is mediated by Abl (Figures 4E, F).